no credit card required  No credit card. No commitment.
 5000 plus G2 reviews  5000+ G2 reviews
Company logo

IM Cannabis (IMC) - Premium Medical Cannabis

IM Cannabis (IMC) - Premium Medical Cannabis


IM Cannabis (IMC) - Premium Medical Cannabis' financial review

Employees

20

Total Funding

16M

nasdaq

IMCC

Market cap

8.1M


IM Cannabis (IMC) - Premium Medical Cannabis information

Premium Medical Cannabis Products for Global Consumers – IM Cannabis (IMC) is one of the world's pioneering medical-grade cannabis companies, with operations in Israel, across Europe, and Canada. Over the past decade, IMC has established its premium medical cannabis brand, comprising a full spectrum of products known for their quality, consistency, and purity, such as 'ROMA', 'TEL AVIV' and 'LONDO...
Premium Medical Cannabis Products for Global Consumers – IM Cannabis (IMC) is one of the world's pioneering medical-grade cannabis companies, with operations in Israel, across Europe, and Canada. Over the past decade, IMC has established its premium medical cannabis brand, comprising a full spectrum of products known for their quality, consistency, and purity, such as 'ROMA', 'TEL AVIV' and 'LONDON'.In Europe, IMC has established a fully operational, vertically integrated medical cannabis business, spearheaded by its EU-GMP certified distribution arm in Germany and augmented by strategic alliances with certified pan-EUGMP certified suppliers.To this end, IMC has formed strong strategic alliances within the international medical cannabis industry, aiming for a dominant position in satisfying the global demand for high-quality medical cannabis products, which both physicians and patients can rely upon.IMC further intends to leverage its expertise in Israel in order to bolster its research and development initiative while collaborating with world-renowned scientists on cutting-edge technology for the benefit of patients around the worldTo find out about investment opportunities with IMC, please contact [Ben Brownstein] at ben.b@imcannabis.com

IM Cannabis (IMC) - Premium Medical Cannabis industries

Pharmaceuticals
Pharmaceuticals & biotechnology
Health care
Pharmaceutical manufacturing

IM Cannabis (IMC) - Premium Medical Cannabis' financial review

Employees

20

Total Funding

16M

nasdaq

IMCC

Market cap

8.1M

Technologies

Notable Alumni

Alec Shifrin
Financial Planning Analyst
Pulsenmore
Yana Fridman
CPA- SVP Finance
Vi
Ben Brownstein
Director Of Business Development
Regubis
Ishai Safian
Business Team Lead
Amdocs

Employees

Manager
CEO IMC holdings
Chief Executive Officer

Prospect on LinkedIn

Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download ExtensionRepresents linkedin prospector
Browse Apollo's Directories

Why our clients choose Apollo

“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Image of Erik Straub

Erik Straub

Head of Product, Kickfurther

“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Image of Michael Transon

Michael Transon

CEO, Victorious

Apollo gives you all the company insights you need

Free to get started, easy to add your whole sales team, commit to monthly or annual plans. We make it easy to get started.